| Ticker Details |
COTY INC
Coty Inc is an American cosmetics company. Its products include fragrances, color cosmetics, hair, body and skin care products. The company markets its products under Calvin Klein, Chloe, Clairol, Marc Jacobs, Wella, Rimmel, and Bourjois brands worldwide.
|
| IPO Date: |
June 13, 2013 |
| Sector: |
Consumer Staples |
| Industry: |
Personal Products |
| Market Cap: |
$1.79B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.23 | 1.71%
|
| Avg Daily Range (30 D): |
$0.06 | 2.68%
|
| Avg Daily Range (90 D): |
$0.05 | 2.09%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
5.53M |
| Avg Daily Volume (30 D): |
6.9M |
| Avg Daily Volume (90 D): |
7.1M |
| Trade Size |
| Avg Trade Size (Sh.): |
228 |
| Avg Trade Size (Sh.) (30 D): |
201 |
| Avg Trade Size (Sh.) (90 D): |
254 |
| Institutional Trades |
| Total Institutional Trades: |
14,706 |
| Avg Institutional Trade: |
$2.9M |
| Avg Institutional Trade (30 D): |
$1.92M |
| Avg Institutional Trade (90 D): |
$2.15M |
| Avg Institutional Trade Volume: |
.25M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.88M |
| Avg Closing Trade (30 D): |
$2.63M |
| Avg Closing Trade (90 D): |
$2.7M |
| Avg Closing Volume: |
589.13K |
|
|
| News |
May 21, 2026 @ 8:59 AM
Facial Serum Market Growth Forecast 2026-2032 Feat...
Source: Researchandmarkets.Com
|
May 18, 2026 @ 11:11 PM
COTY DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL,...
Source: Rosen Law Firm
|
May 18, 2026 @ 8:58 PM
Bragar Eagel & Squire, P.C. Urges Coty, Inc. Stock...
Source: Bragar Eagel & Squire, P.C.
|
May 15, 2026 @ 1:00 PM
COTY Shareholder Alert: Coty Inc. Securities Class...
Source: The Gross Law Firm
|
May 14, 2026 @ 6:45 PM
DEADLINE ALERT for ATRA, COTY, SMCI, IBRX: Law Off...
Source: Law Offices Of Howard G. Smith
|
| Financials |
| |
TTM |
Q3 2026 |
Q2 2026 |
|
Basic EPS
|
$-.62
|
$-.47
|
$-.14
|
|
Diluted EPS
|
$-.62
|
$-.47
|
$-.14
|
|
Revenue
|
$5.79B
|
$1.28B
|
$1.68B
|
|
Gross Profit
|
$3.66B
|
$791.9M
|
$1.07B
|
|
Net Income / Loss
|
$-517.2M
|
$-405.7M
|
$-116.2M
|
|
Operating Income / Loss
|
$-23.3M
|
$-372M
|
$148.2M
|
|
Cost of Revenue
|
$2.13B
|
$489.7M
|
$608M
|
|
Net Cash Flow
|
$10.8M
|
$-177.8M
|
$174.9M
|
|
PE Ratio
|
|
|
|
|
|
|